Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases

Nirit Hanin-Avraham, Bianca Fuhrman, Agnieszka Mech-Dorosz, Sofiya Kolusheva, Angel Porgador, Michael Aviram, Raz Jelinek

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Changes in the abundance and properties of blood lipoproteins are generally considered major causes for varied pathological conditions and diseases. Using novel chromatic biomimetic vesicle and cell assays, we present here for the first time evidence for significant changes in lipoproteins' interactions with artificial membranes. Specifically, we demonstrate significant differences in membrane binding between lipoproteins (both low-density lipoprotein [LDL] and high-density lipoprotein [HDL]) harvested from diabetic patients vs. healthy controls as well as between oxidized and native lipoproteins. The chromatic assays, complemented by biophysical techniques and electron microscopy, point to significant reduction of surface membrane binding of the lipoproteins as a consequence of diabetes or oxidation. Overall, our results indicate that the substantial modulation of membrane interactions revealed by the chromatic assays may be used as a new and potentially powerful marker for screening and prediction of diseases associated with oxidative stress.

Original languageEnglish
Pages (from-to)2436-2443
Number of pages8
JournalBiochimica et Biophysica Acta - Biomembranes
Issue number11
StatePublished - 1 Nov 2009

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology


Dive into the research topics of 'Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases'. Together they form a unique fingerprint.

Cite this